Table 1 Characteristics of patients, facilities, and providers in the Busoga sub-region, 2020
Variable | All | Level of heath facility | Owner of health facility | ||||
|---|---|---|---|---|---|---|---|
IV | III | II | GOU | PNFP | PFP | ||
Patient characteristics | |||||||
 Number of patients | 3936 | 363 | 1398 | 2175 | 3414 | 323 | 199 |
 Females, n (%) | 2497 (63.4) | 229 (63.0) | 873 (62.4) | 1395 (64.1) | 2193 (64.2) | 193 (59.7) | 111 (55.8) |
 Age in years, median (IQR) | 14 (3, 27) | 10 (2, 25) | 14 (3, 27) | 14 (3, 27) | 13 (3, 26) | 14 (2, 25) | 23 (3, 28) |
Age category | |||||||
 < 5 years, n (%) | 1235 (31.4) | 126 (34.7) | 429 (30.7) | 680 (31.3) | 1057 (31.0) | 116 (35.9) | 62 (31.2) |
 5 to < 15 years, n (%) | 776 (19.7) | 74 (20.3) | 287 (20.5) | 415 (19.1) | 714 (20.9) | 46 (14.2) | 16 (8.0) |
 > 15 to 45 years, n (%) | 1643 (41.7) | 141 (38.8) | 552 (39.5) | 950 (43.7) | 1394 (40.8) | 144 (44.6) | 105 (52.8) |
 > 45 years, n (%) | 282 (7.2) | 22 (6.1) | 130 (9.3) | 130 (5.9) | 249 (7.3) | 17 (5.3) | 16 (8.0) |
 High (> 37.5 °C) temperature, n (%) | 1267 (32.2) | 144 (39.7) | 373 (26.7) | 750 (34.5) | 1106 (32.4) | 103 (31.9) | 58 (29.2) |
 Illness duration (days), median (IQR) | 3 (2, 5) | 3 (3, 6) | 3 (2, 5) | 3 (2, 4) | 3 (2, 5) | 3 (2, 6) | 3 (2, 3) |
 Prior use of anti-malarials, n (%) | 631 (16.0) | 59 (16.2) | 242 (17.3) | 330 (15.1) | 537 (15.7) | 47 (14.5) | 47 (23.6) |
Health facility characteristics | |||||||
 Number of facilities | 392 | 16 | 101 | 275 | 285 | 76 | 31 |
 Supervised in MCM 2019/2020, n (%) | 59 (15.1) | 4 (25.0) | 25 (24.7) | 30 (10.9) | 35 (12.3) | 16 (21.1) | 8 (25.8) |
Availability of equipment/medicines | |||||||
 Weighing scale, n (%) | 340 (86.7) | 16 (100.0) | 99 (98.0) | 225 (81.8) | 238 (83.5) | 71 (93.4) | 31 (100.0) |
 Thermometer, n (%) | 255 (65.0) | 12 (75.0) | 93 (92.0) | 150 (54.5) | 158 (55.4) | 66 (86.8) | 31 (100.0) |
 Malaria test, n (%) | 355 (90.6) | 16 (100.0) | 99 (98.0) | 240 (87.2) | 253 (88.8) | 71 (93.4) | 31 (100.0) |
 AL pack of any type in stock, n (%) | 300 (76.5) | 12 (75.0) | 88 (87.1) | 200 (72.7) | 204 (71.6) | 71 (93.4) | 25 (80.7) |
Availability of guidelines/charts | |||||||
 IMM guidelines 2014, n (%) | 92 (23.5) | 4 (25.0) | 38 (37.6) | 50 (18.2) | 65 (22.8) | 19 (25.0) | 8 (25.8) |
 IMCI guidelines, n (%) | 136 (34.7) | 9 (56.3) | 67 (66.3) | 60 (21.8) | 109 (38.3) | 24 (31.6) | 3 (9.7) |
 UCG, n (%) | 276 (70.4) | 15 (93.8) | 91 (90.1) | 170 (61.8) | `212 (74.4) | 55 (72.4) | 9 (29.0) |
 AL dosing procedures, n (%) | 98 (25.0) | 8 (50.0) | 45 (44.5) | 45 (16.4) | 78 (27.4) | 14 (18.4) | 6 (19.4) |
 % of vacancies filled, median (IQR) | 56 (33, 78) | 76 (70, 85) | 79 (63, 95) | 56 (33, 67) | 66 (44, 79) | 50 (33, 67) | 55 (33, 67) |
Health care worker characteristics | |||||||
 Number of health care workers, N | 1718 | 219 | 709 | 790 | 1349 | 251 | 118 |
Position | |||||||
 Doctor, n (%) | 11 (0.6) | 7 (3.2) | 4 (0.6) | 0 | 8 (0.6) | 2 (0.8) | 1 (0.9) |
 Clinical Officer, n (%) | 174 (10.1) | 39 (17.8) | 110 (15.5) | 25 (3.2) | 145 (10.8) | 21 (8.4) | 8 (6.8) |
 Registered nurse, n (%) | 241 (14.0) | 47 (21.5) | 114 (16.1) | 80 (10.1) | 205 (15.2) | 33 (13.2) | 3 (2.5) |
 Enrolled nurse, n (%) | 831 (48.3) | 94 (42.9) | 332 (46.8) | 405 (51.3) | 622 (46.1) | 125 (49.8) | 84 (71.2) |
 Nursing assistant, n (%) | 378 (22.0) | 21 (9.6) | 107 (15.1) | 250 (31.7) | 303 (22.5) | 56 (22.3) | 19 (16.1) |
 Laboratory staff, n (%) | 36 (2.1) | 5 (2.3) | 26 (3.7) | 5 (0.6) | 28 (2.1) | 6 (2.4) | 2 (1.7) |
 Other, n (%) | 47 (2.7) | 6 (2.7) | 16 (2.3) | 25 (3.1) | 38 (2.8) | 8 (3.2) | 1 (0.9) |
In service training in the past 5Â years | |||||||
 IMCI, n (%) | 583 (36.7) | 70 (32.0) | 283 (39.9) | 230 (29.1) | 447 (33.1) | 90 (35.9) | 46 (39.0) |
 MCM, n (%) | 628 (36.6) | 87 (39.7) | 296 (41.7) | 245 (31.0) | 486 (36.0) | 93 (37.0) | 49 (41.5) |
Access to guidelines | |||||||
 IMM guidelines, n (%) | 1064 (61.9) | 134 (61.2) | 500 (70.5) | 430 (54.4) | 879 (65.2) | 141 (56.2) | 44 (37.3) |
 UCG, n (%) | 1442 (83.9) | 173 (79.0) | 634 (89.4) | 635 (80.4) | 1189 (88.1) | 181 (72.1) | 72 (61.0) |
Knowledge of malaria treatment policy | |||||||
 Malaria test for all fevers, n (%) | 1634 (95.1) | 210 (95.9) | 669 (94.4) | 755 (95.6) | 1279 (94.8) | 239 (95.2) | 116 (98.3) |
 Anti-malarials to only positives, n (%) | 1624 (94.5) | 213 (97.2) | 666 (93.9) | 745 (94.3) | 1281 (94.9) | 230 (91.6) | 113 (95.7) |
 1st line treatment for UM, n (%) | 1555 (90.5) | 200 (91.3) | 655 (92.4) | 700 (88.6) | 1237 (91.7) | 227 (90.4) | 91 (77.1) |
 Alt. 1st line treatment for UM, n (%) | 332 (19.3) | 23 (10.5) | 164 (23.1) | 145 (18.4) | 246 (18.2) | 84 (33.5) | 2 (1.7) |
 2nd line Rx for UM, n (%) | 463 (27.0) | 63 (28.8) | 265 (37.4) | 135 (17.1) | 380 (28.2) | 73 (29.1) | 10 (8.5) |